These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35023914)

  • 1. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.
    Ohar JA; Ferguson GT; Mahler DA; Drummond MB; Dhand R; Pleasants RA; Anzueto A; Halpin DMG; Price DB; Drescher GS; Hoy HM; Haughney J; Hess MW; Usmani OS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():79-92. PubMed ID: 35023914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease.
    Loh CH; Ohar JA
    Curr Opin Pulm Med; 2024 Mar; 30(2):174-178. PubMed ID: 38164804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
    Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
    Anderson M; Collison K; Drummond MB; Hamilton M; Jain R; Martin N; Mularski RA; Thomas M; Zhu CQ; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2021; 16():933-943. PubMed ID: 33883890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
    Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.
    Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
    Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons between In-Check DIAL® and PF810® in evaluation and training inspiratory capacity for using dry powder inhalers.
    Wu Y; Li L; Gong Y; Li X; Ye X; Zhang J
    BMC Pulm Med; 2024 Aug; 24(1):380. PubMed ID: 39095773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
    Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
    Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
    Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD.
    Mahler DA; Niu X; Deering KL; Dembek C
    Int J Chron Obstruct Pulmon Dis; 2022; 17():559-568. PubMed ID: 35313719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases.
    Ding N; Zhang W; Wang Z; Bai C; He Q; Dong Y; Feng X; Zhang J; Gao S
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1913-1924. PubMed ID: 34188467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
    Barnes CN; Mahler DA; Ohar JA; Lombardi DA; Crater GD
    Chest; 2020 Oct; 158(4):1413-1419. PubMed ID: 32343967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.
    Malmberg LP; Rytilä P; Happonen P; Haahtela T
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on Physical Position of Peak Inspiratory Flow in Stable COPD: An Observational Study.
    Pleasants RA; Henderson AG; Bayer V; Shaikh A; Drummond MB
    Chronic Obstr Pulm Dis; 2024 Mar; 11(2):174-186. PubMed ID: 38236166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.
    Leving MT; van Boven JFM; Bosnic-Anticevich SZ; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; García Pardo M; Gardev A; Gawlik R; van der Ham I; Hartgers-Gubbels ES; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price DB; Roman-Rodríguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani OS; Kocks JH
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2401-2415. PubMed ID: 36185173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.
    Leving MT; Bosnic-Anticevich S; van Cooten J; de Sousa JC; Cvetkovski B; Dekhuijzen R; Dijk L; Pardo MG; Gardev A; Gawlik R; van der Ham I; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Emerson-Stadler R; Kocks JWH
    NPJ Prim Care Respir Med; 2022 Dec; 32(1):59. PubMed ID: 36575175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume.
    Haikarainen J; Vahteristo M; Lähelmä S; Vartiainen V; Malmberg LP
    J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):305-313. PubMed ID: 32423277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.